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EGFROur previous study indicated that speciﬁcity protein-1 (Sp1) is accumulated during hypoxia in an internal
ribosomal entry site (IRES)-dependent manner. Herein, we found that the Sp1 was induced strongly at the
protein level, but not in the mRNA level, in lung tumor tissue, indicating that translational regulation might
contribute to the Sp1 accumulation during tumorigenesis. A further study showed that the translation of Sp1
was dramatically induced through an IRES-dependent pathway. RNA immunoprecipitation analysis of proteins
bound to the 5′-untranslated region (5′-UTR) of Sp1 identiﬁed interacting protein — nucleolin. Knockdown of
nucleolin signiﬁcantly inhibited IRES-mediated translation of Sp1, suggesting that nucleolin positively facilitates
Sp1 IRES activation. Further analysis of the interaction between nucleolin and the 5′-UTR of Sp1 mRNA revealed
that the GAR domain was important for IRES-mediated translation of Sp1. Moreover, geﬁtinib, and LY294002
and MK2206 compounds inhibited IRES-mediated Sp1 translation, implying that activation of the epithelial
growth factor receptor (EGFR) pathway via Akt activation triggers the IRES pathway. In conclusion, EGFR
activation-mediated nucleolin phosphorylated at Thr641 and Thr707 was recruited to the 5′-UTR of Sp1 as an
IRES trans-acting factor to modulate Sp1 translation during lung cancer formation.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Speciﬁcity protein-1 (Sp1) expressed inmammalian cells belongs to
the Speciﬁcity Protein/Krüppel-like Factor (SP/KLF) transcription
factor family [1]. Sp1 contains a DNA binding domain with 3 adjacent
Cys2His2-type zinc ﬁngers that can activate or repress transcription in
response to physiological and pathological stimuli [2]. Sp1 target
genes are involved in cell cycle progression and arrest [3], apoptosis
[4], differentiation [5] and tumorigenesis [6]. Compared to the expres-
sion in normal tissues or cells, the expression of Sp1 is higher in breast
carcinomas [7,8], thyroid cancer [9], hepatocellular carcinomas [10,
11], pancreatic cancer [12], colorectal cancer [13], gastric cancer [14,
15] and lung cancer [1,16]. Sp1 levels are tightly regulated in the
different stages of tumorigenesis to inﬂuence the cancer progressions and Biosignal Transduction,
.: +886 6 275 7575; fax: +886
g).[17]. Previous studies of Sp1 expression in tumorigenesis suggested
that increased transcription is the most important mechanism for Sp1
accumulation during cancer formation [18,19]. Our previous studies
indicated that phosphorylation of Sp1 by c-Jun NH2-terminal kinase-1
(JNK-1) increases Sp1 stability during mitosis [20]. Heat shock
protein-90 also maintains Sp1 stability, and attenuation of Sp1
sumoylation increases Sp1 stability [4,16]. Recently, we also found
that the interplay between two intramolecular post-translational
modiﬁcations, phosphorylation and sumoylation modulates the Sp1
protein stability by controlling the recruitment of RNF4, an E3-ligase
[21]. In addition, we found that Sp1 is induced quickly through a cap-
independent pathway manner under hypoxic conditions [22]. In
addition to increased transcription and protein stability, whether the
cap-independent translational pathway also enhances Sp1 expression
during tumorigenesis is still not clear.
Translation initiation usually occurs through a cap-dependent
pathway. However, previous studies indicated that cap-independent
translation is an alternative pathway in response to some sub-
environmental or stressful conditions [23,24]. Moreover, IRES elements
were ﬁrst found in poliovirus and encephalomyocarditis virus (EMCV)
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host proteins when viral RNAs contain IRES [26,27]. Recent studies
indicated that many cellular mRNAs, such as those encoding cyclin D1
and c-myc also contain IRES elements within their 5′-UTR to regulate
their translational activity [28]. Moreover, the cellular inhibitor of apo-
ptotic protein 1 (cIAP1) may also contain an IRES motif within its 5′-
UTR [29]. The IRES is a speciﬁc RNA sequence localized within the 5′-
UTR and near the translational initiation codon. The recent studies
showed that IRES elements possess complex secondary and tertiary
structures that fold into four domains with distinct functions [30,31].
Domain I is dispensable for translational activity, but is critical for viral
replication. Domain II enhances the IRES activity. Domain III composed
of several sub-domains, which are essential for ribosomal recruitment.
Domain IV contains the initiator AUG codon [30]. Other studies also
reveal that a number of such virus elements appear to be resistant to
the loss of ternary complexes (eIF2GTPmet-tRNA) and the term “eIF2-
less initiation” has been used [32–37]. In addition to the cis-effect of
the RNA sequence itself, several important proteins deﬁned as IRES
trans-activating factors (ITAFs) can be recruited to the IRES motif
to stabilize the functional IRES conformation and serve as additional
bridges between the IRES and the ribosome [38–41]. Many ITAFs be-
long to the group of heterogeneous nuclear ribonucleoproteins
known to shuttle between the nucleus and the cytoplasm [38]. For
example, heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1)
mediates rapamycin-induced alterations of cyclin D1 and c-myc
IRES activity [28]. Recent studies indicate that IRES-mediated trans-
lation did not only occur on the viral infective condition. Several sig-
nal pathway and physiological conditions have been studied about
the involvement of IRES-mediated translation. On the oxidative
stress condition, elongation factor 2 diphthamide is important for
the translation of XIAP and FGF2 express via IRES-dependentmanner
[42]. On cancer formation, dysregulating IRES-mediated translation
which contributes to overexpression of Aurora A kinase has been
reported [43]. IRES-dependent translation of dMyc is involved in
the CNBP-regulated wing development [44]. In addition, hnRNP A1
induces IRES-dependent translation of SREBP-1a in response to en-
doplasmic reticulum stress [45]. A recent study also reveals that
GPCR activation leads to eIF4G phosphorylation at the 5′ cap and
IRES-mediated translation [46]. Finally, another function of IRES-
mediated translation is to regulate the isoform(s) expression.
Annexin A2 and PSF are involved in the regulation of both p53 iso-
forms [47]. However, a limited number of ITAFs have been identiﬁed
to date, and it is not yet fully understood how they control transla-
tion and which cellular pathways are involved.
Nucleolin is a multifunctional protein principally localized not only
in the nucleolus, but also found in the cytoplasm and cell membrane.
Nucleolin plays an important role in many cellular processes, such as
chromatin remodeling, transcription of ribosomal RNA, rRNA matura-
tion, ribosome assembly and ribosome biogenesis [48]. Previously, a
study indicated that nucleolin enhanced G-rich sequence in 3′- or 5′-
UTR of target mRNAs [49]. Nucleolin can also bind to mRNA and medi-
ated mRNA translation andmRNA turnover [50]. The N-terminal region
of nucleolin,which containsmultiple phosphorylation sites, participates
in the transcription of rRNA. The central region of nucleolin contains 4
RNA-recognition motifs (RRMs) and mediates the interaction with
mRNAs and pre-rRNA. The C-terminal region of nucleolin contains an
arginine/glycine-rich (GAR) domain, throughwhichnucleolin can inter-
act with target mRNAs [51]. Previous studies indicated that nucleolin is
an IRES trans-acting factor (ITAF) that modulates IRES-mediated trans-
lation [52,53].
In the present study, we found that the activation of the EGFR path-
way during lung cancer formation is involved in the IRES-mediated
translation of Sp1 through the recruitment of nucleolin to the 5′-UTR
of Sp1 mRNA. This study provides a novel mechanism, in addition to
those that regulate Sp1 transcription and protein stability, for Sp1 in-
duction during tumorigenesis.2. Material and methods
2.1. Cell culture and transfection
Beas2B, HeLa, and A431 cell lines and human lung cancer cell lines,
H1299 and A549, were purchased from American Type Culture Collec-
tion (Manassas, VA, USA). HeLa, H1299 and A549 cell lines were cul-
tured in Dulbecco's modiﬁed Eagle's medium (DMEM) containing 10%
fetal bovine serum, 100 mg/ml streptomycin sulfate and 100 U/ml pen-
icillin G sodiumat 37 °C and 5%CO2. A431 cellswere cultured inDMEM-
low glucose with the above supplements. Beas2B cells were cultured in
BEGMmedium (LONZA,Walkersville, MD, USA) with the above supple-
ments. Transfection with indicated plasmid was performed using
PolyJet (SignaGen Laboratories, Rockville, MD, USA) and Lipofecta-
mine™ 2000 (Invitrogen) according to the manufacturer's instruction
with a slight modiﬁcation.
2.2. Reporter assay
Cells were replated 24 h before transfection at an optimal cell densi-
ty in a 6-well plate. Cells were transfectedwith pRF or pRSp1F plasmids
for 24 h. Following 24 to 36 h transfection, cells were harvested and
subjected to luciferase assay by using dual-luciferase reporter assay kit
(Promega, Madison, WI, USA). The reporter activity was normalized
with the Renilla luciferase activity.
2.3. Western blot
Total cell lysates were fractionated using sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred
onto a polyvinylidene diﬂuoride (Millipore) membrane using a
transfer apparatus according to the manufacturer's protocols (Bio-
Rad Laboratories, Inc., Hercules, CA). After incubation with 5% non-
fat milk in TBST (10 mM Tris, pH 8.0, 150 mM NaCl, and 0.05%
Tween 20) for 1 h, the membranes were incubated with anti-Sp1
(Millipore, Bedford, MA, USA), anti-nucleolin (Santa Cruz Bio-
technology), anti-phospho-nucleolin (T641 and T707; Kelowna,
Taiwan), anti-phospho-EGFR(Y-1068), anti-phospho-Akt (S473; Ep-
itomics, Burlingame, CA, USA), anti-ERK (Cell Signaling Technology,
Boston, MA, USA), anti-pERK (Cell Signaling Technology) or anti-
tubulin (Sigma) antibody at 4 °C overnight. The membranes were
then washed with TBST and incubated with secondary antibodies
(Millipore) at room temperature for 1 h blots. After washing with
TBST, blots were developed using the ECL system.
2.4. RNA extraction and reverse transcription-polymerase chain
reaction (RT-PCR)
Total RNA of HeLa cells was isolatedwith TRIzol reagent (Invitrogen,
Carlsbad, CA) and 3 μg of RNA was subjected to RT-PCR with Super-
ScriptII (Invitrogen). The primers used are listed as follows: for Sp1 5′-
UTR forward: 5′- ACTAGTAGCGAGTCTTGCCATTGG-3′ and reverse: 5′-
GGCGCCGGTGGCAGCTGAGGGACA-3′, Sp1 forward: 5′-TGCAGCAGAA
TTGAGTCACC-3′, for GAPDH forward: 5′-CCATCACCATCTTCCAGGAG-
3′ and reverse: 5′-CCTGCTTCACCACCTTCTTG-3′, for ﬁreﬂy luciferase
forward: 5′-GAGCACGGAAAGACGATG-3′ and reverse: 5′-GCCTTTATGA
GGATCTCTCTGA-3′, and for Renilla luciferase forward: 5′-AAAGGTGAA
GTTCGTCGTCCAAC-3′ and reverse: 5′-TTTGAGAACTCGCTCAACGAACG-
3′.
2.5. RNA interference
RNA interference vectors that were used in this study and were ob-
tained from the National RNAi Core Facility in the Institute of Molecular
Biology, Academia Sinica (Taipei, Taiwan) are as follows: pLKO.1-
shRNA-nucleolin-#1 (target sequence, 5′-CGGTGAAATTGATGGAAA
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GAGGTAGAAGAAGAT-3′).
2.6. In vitro RNA synthesis
The plasmid pGEM-Sp1-5′-UTRwas linearized to serve as templates
to generate RNA probe for pulldown or translational assays. The RNAs
were synthesized using the Riboprobe in vitro Transcription system
(Promega). The linearized DNA template was transcribed by SP6/T7
polymerase in the presence of 2.5 mM UTP, CTP, ATP, and GTP. After
1 h incubation at 37 °C, the reaction was stopped by adding 2 U of
RQ1RNase-free DNaseI (Promega) for 15min at 37 °C. The RNAwas pu-
riﬁed with columns for pull-down assay.
2.7. Biotin pull-down assay
The biotin-labeled RNA incubated with HeLa cell lysates for 4 h at
4 °C. The RNA–protein complex was isolated by streptavidin-
conjugated agarose beads and washed with wash buffer (10 mM
HEPES, pH 8.0, 40 mM KCl, 3 mM MgCl2, 5% glycerol, 2 mM DTT,
and 2% NP-40) supplemented with protease inhibitors (1 mg/ml
leupeptin, 1 mg/ml aprotinin, and 0.5 mM phenylmethylsulfonyl
ﬂuoride). The RNA–protein complex was analyzed by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE).
2.8. RNA immunoprecipitation assay (RNA-IP)
Cells were harvestedwith lysis buffer (10mMHEPES, pH8.0, 40mM
KCl, 3 mM MgCl2, 5% glycerol, 0.5% NP-40, and 1 U/μl RNaseOUT) for
20min on ice. The total cell extracts were incubatedwith anti-nucleolin
antibody (Santa Cruz Biotechnology) and protein A/G agarose beads
(Millipore) at 4 °C overnight. Immunoprecipitated complexes were
washed with lysis buffer and total RNA was extracted by TRIzol reagent
(Invitrogen). The mRNA was detected by RT-PCR analysis.
2.9. Polysomal fractionation
HeLa cells were treated with 100 mg/ml cycloheximide (Sigma)
5 min prior to harvest. Total lysates were lysed in polysome lysis buffer
(100mMKCl, 5mMMgCl2, 10mMHEPES, 1% TritonX-100, 0.5% sodium
deoxycholate, 100 U/ml RNase inhibitor, 100 mg/ml of cycloheximide)
containing protease inhibitors (1 mg/ml leupeptin, 1 mg/ml aprotinin,
and 0.5 mM phenylmethylsulfonyl ﬂuoride) and rotated for 10 min at
4 °C. The total lysates were loaded onto a 5–40% (wt/vol) sucrose solu-
tion in polysome lysis buffer (500mMKCl and 20U/ml RNase inhibitor).
Samples were centrifuged at 39,000 rpm for 2.5 h at 4 °C in a Sorvall
SW41Ti rotor (Newtown, CT, USA). Fractions of equal volume were
collected from the top. RNA in each fraction was extracted using TRIzol
reagent (Invitrogen).
2.10. Histological analysis and immunohistochemistry
The lungs excised from the transgenic mice were ﬁxed in 10%
neutral buffer formalin for 24 h, dehydrated, and embedded in parafﬁn.
Sections (5 mm) were cut and stained with hematoxylin and eosin
(H&E). For immunohistochemistry, sections were dewaxed in xylene
and rehydrated in a graded series of ethanol. Endogenous peroxidase
was blocked by 0.3% H2O2 in PBE for 30 min. Sections were blocked by
3% BSA in PBS, and then incubated with diluted primary antibodies for
2 h at room temperature. The immunoreactivity was visualized with a
Vectastain ABC kit (Vector Laboratories, Burlingame, CA, USA).
2.11. Statistical analysis
Student's t-test was used to analyze the difference between the two
groups. Polysome fraction curves were calculated according to the two-way analysis of variance (ANOVA). The p-value of b0.05was considered
statistically signiﬁcant.
3. Results
3.1. Cap-independent translational activity contributes to Sp1
accumulation during tumorigenesis
Sp1 accumulation during tumorigenesis is important for cancer pro-
gression [17,54]. Therefore, we ﬁrst measured Sp1 protein and mRNA
levels in clinical lung cancer specimens (Fig. 1A and B). Sp1 protein
level was signiﬁcantly higher in cancer tissue samples than in normal
tissue samples; however, no signiﬁcant differences were observed be-
tween Sp1mRNA levels in 8 normal tissue samples and 8 lung cancer
tissue samples, implying that transcriptional upregulation is not
the major mechanism for Sp1 accumulation during tumorigenesis
(Fig. 1C). To conﬁrm this result, Sp1 protein and mRNA levels were
also studied in K-rasG12D-mediated lung cancer mice, induced by doxy-
cycline (Fig. 1D and E). Sp1 protein level was dramatically increased
after 3, 6 and 9 months of treatmentswith doxycycline, but only a slight
increase in the Sp1mRNA level was observed (Fig. 1E). Finally, Sp1 pro-
tein and mRNA levels were examined in a normal lung epithelium cell
line, Beas2B, and several cancer cell lines, A549, H1299, HeLa, and
A431 cells (Fig. 1F). Sp1 protein level was higher in these cancer cell
lines than in normal lung epithelium cells; however, no signiﬁcant
difference in Sp1 mRNA level was observed between the normal and
cancer cells (Fig. 1F). Taken together, these results indicate that Sp1 ac-
cumulation during cancer formation was, at least in part, due to the
increased translational efﬁciency or protein stability.
We previously identiﬁed an IRES-motif within the 5′-UTR of Sp1 [22].
Therefore, we investigated whether the cap-independent pathway
modulates Sp1 expression during tumorigenesis (Supplementary
Fig. 1). To determine whether Sp1 accumulation resulted from IRES-
mediated translation during tumorigenesis, a bicistronic reporter
construct containing the Renilla and ﬁreﬂy luciferase genes was used
to study the IRES activity (Supplementary Fig. 1A and B). No signiﬁcant
differencewas observed in themRNA levels of ﬁreﬂy and Renilla lucifer-
ases, suggesting that the insertion of the 5′-UTR of Sp1 between Renilla
luciferase and ﬁreﬂy luciferase does not affect the transcriptional activ-
ity (Supplementary Fig. 1B (b)).We thenmeasured luciferase activity in
various cell lines. In Beas2B cells, pRSp1F inducedﬁreﬂy luciferase activ-
ity was approximately 7 times higher than pRF induced. In H1299, A549,
and HeLa cells, pRSp1F induced ﬁreﬂy luciferase activities were 30, 23,
and 300 times higher than pRF induced, respectively (Supplementary
Fig. 1B (a)). Cap-independent translational activity was also studied
using phRF and phRSp1F vectors that encode a hairpin structure to
block cap-dependent translation. As shown in Supplementary Fig. 1D,
phRSp1F induced higher ﬁreﬂy luciferase activity in A549, H1299 and
HeLa cells than that induced by phRF, indicating that the 5′-UTR of
Sp1 contributed to Sp1 induction by enhancing translational activity.
Our results indicate that the IRES-motif within the 5′-UTR of Sp1
increases Sp1 translation in a cap-independent manner during
tumorigenesis.
3.2. Nucleolin is involved in cap-independent translation of Sp1
Previous studies indicate that the conserved binding motif of
nucleolin is 5′-TTAGGG-3′ [55,56]. The Sp1 IRES-motif was compared
with this binding motif (Fig. 2A (a)). Two sites within 5′-UTR of Sp1
are similar to this motif, implying that nucleolin may bind to the Sp1
5′-UTR region. Moreover, we also addressed the expression levels of
nucleolin in normal cells and different cancer cell lines (Fig. 2A (b)).
These results showed that nucleolin was highly expressed in cancer
cells but not in normal cells. To determine whether nucleolin was
involved in Sp1 IRES activation, bicistronic vectors with GFP and GFP-
nucleolin were co-transfected into HeLa cells to study the luciferase
Fig. 1. Sp1 is accumulated in tumorigenesis. Sp1 level in clinical normal lung tissue and lung adenocarcinoma was studied by IHC staining (A) and Western blot (B) with anti-Sp1 anti-
bodies. ThemRNA levels in clinical patients' lung tissueswere assayed by q-PCR (C). After doxycycline (0.5 g/l) treatment for 0, 3, 6 and 9 months inK-rasG12D transgenicmice, lung tissues
were collected for studying the Sp1 protein andmRNA levels using immunohistochemical staining (D) andWesternblotwith anti-Sp1 antibodies and RT-PCR (E), respectively. Sp1 protein
and mRNA levels in various cell lines were studied by Western blot and real-time PCR analyses. The levels of Sp1 protein and mRNA were quantiﬁed after ﬁnishing three independent
experiments (F). Data are represented as mean ± s.e.m (*p b 0.05, **p b 0.01).
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increased by nucleolin overexpression, but it was decreased by knock-
down of nucleolin (Fig. 2C), suggesting that nucleolin positively affected
the IRES-mediated translation of Sp1. To determine whether nucleolin
was recruited to the 5′-UTR of Sp1, pGEM-Sp1-5′-UTR RNA transcribed
in vitro was used as a probe to study the interaction between nucleolin
and the IRES-motif (Fig. 2D (a)). Our results indicated that nucleolin
was recruited to the IRES-motif of the Sp1 5′-UTR region, but could
not recruit hnRNPQ,whichwas not predicted in 5′UTRof Sp1, indicatingthat nucleolin can be recruited to the 5′-UTR of Sp1 speciﬁcally. Further-
more, RNA-immunoprecipitation (IP) using anti-nucleolin antibodies
also indicated that nucleolin interacted with the 5′-UTR of Sp1
(Fig. 2D (b)). When nucleolin-binding motifs within the 5′-UTR of Sp1
were mutated (pRSp1F-M1 and pRSp1F-M2; Fig. 2E (a)), the luciferase
activity of pRSp1F-M2 was decreased, but no alteration in pRSp1F-M1
was observed (Fig. 2E (b)). In addition, using the 5′-UTR of Sp1 and its
mutants conjugated with biotin as probes to recruit nucleolin showed
that the loss of the nucleolin-binding motif on the M2 region abolished
Fig. 2. Nucleolin is involved in IRES-mediated translation of Sp1. (A) Predication of the RNA binding proteins is by the preferred binding sequence of Sp1 5′-UTR (250 bp) (a). Nucleolin
protein levels in Beas2B, A549, H1299, HeLa, and A431 cell lines thatwere assayed byWestern blot (b). (B) The pRF and pRSp1F vectorswere co-transfectedwithGFP orGFP-nucleolin into
HeLa cells. After transfection for 24 h, the ﬁreﬂy and Renilla luciferase activities weremeasured by reporter assay. (C) Knockdown of nucleolin by lentivirus with shRNA-NCL infection for
48 h. pRF and pRSp1F vectors were transfected into HeLa cells with nucleolin knockdown for 24 h, then luciferase activities were measured by reporter assay. (D) In vitro transcribed
pGEM-Sp1-5′-UTR RNA as a probe was incubated with total cell lysates of HeLa cells. The pulldown mixtures were analyzed using immunoblotting with anti-nucleolin antibodies
(a panel). The HeLa cell lysates were incubated with anti-nucleolin antibodies for immunoprecipitation, and then total RNA was isolated for RT-PCR analysis (b panel). (E) Nucleolin-
binding motifs within Sp1 5′-UTR were mutated, pRSp1F-M1 and pRSp1F-M2. These plasmids were transfected into HeLa cells for studying the luciferase activity after 24 h incubation
(a). Probes synthesized by in vitro transcription were used for pull-down assay. Samples were then analyzed with Western blot using anti-nucleolin antibodies (b). (F) Sp1 5′-UTR and
thrombomodulin 5′-UTR were constructed into pGL3, then transfected into HeLa cells for luciferase activity assay (a) and RNA-IP assay with anti-nucleolin antibodies (b). Total RNA
was extracted from immunoprecipitation samples for RT-PCR. Data are representative of three independent experiments and as mean ± s.e.m (**p b 0.01, and ***p b 0.001).
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nally, 5′-UTRs of Sp1with nucleolin bindingmotif and thrombomodulin
(TM) without nucleolin binding motif were constructed into the
monocistronic plasmid, pGL3, to study the effect of nucleolin mediated
translation of Sp1 (Fig. 2F). Nucleolin overexpression dramatically in-
creased luciferase activity of pGL3-Sp15′-UTR, suggesting that the 5′-UTR of Sp1 is important for nucleolin-induced Sp1 expression (Fig. 2F
(a)). To rule out the effect of cap-dependent translation, the mTOR
inhibitor, rapamycin, treated the GFP-NCL overexpressed cells (Sup-
plementary Fig. 3C). No signiﬁcant inhibition after rapamycin treatment
was found in the reporter activity of pGL3-Sp1-5′UTR, implying
that nucleolin-mediated translational activity is through the cap-
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was recruited to the 5′-UTR of Sp1, but not to the 5′-UTR of TM (Fig. 2F
(b)), suggesting that nucleolin formed a complexwith the IRES of Sp1 to
modulate Sp1 translation.
Therefore, Sp1 expression was then measured in several cancer cell
lines, including HeLa, H1299 and A431 cells, after the knockdown of
nucleolin (Fig. 3A). Sp1 decreased in cells with nucleolin knockdown,
indicating that nucleolin positively regulated Sp1 expression. Finally,
the efﬁciency of ribosome recruitment to Sp1 mRNA after knockdown
of Sp1was studied using a polysomeproﬁling assay (Fig. 3B). No change
was detected in the total ribosome distribution in the fractions (Fig. 3B
(a)), and nucleolin knockdown did not alter the polysome distribution
on GAPDH mRNA (Fig. 3B (b)). The polysome distribution curve on
Sp1mRNA, however, was shifted to the left by nucleolin knockdown, in-
dicating that the efﬁciency of ribosome recruitment declined with
nucleolin knockdown (Fig. 3B (c)). In addition, previous studies indicate
that protein stability contributes to Sp1 accumulation during tumori-
genesis [4,20,21]. Here we studied whether nucleolin affects Sp1 stabil-
ity, and data, as shown in Supplementary Fig. 2, indicated that nucleolin
knockdown did not affect the Sp1 half-life. Taken together, our results
show that nucleolin is recruited to Sp1 5′-UTR to increase the IRES-
mediated translation of Sp1.Fig. 3.Nucleolin increases Sp1 expression through enhancing ribosome recruitment. (A) Nucleo
collected forWestern blot using antibodies against Sp1, nucleolin and tubulin. (B) Nucleolinwa
RNAwas isolated from the 18 fractions for RT-PCR using the primers from Sp1 (b) and GAPDH a
mean ± s.e.m (*p b 0.05, and ***p b 0.001).3.3. GAR domain of nucleolin is important for the interaction of nucleolin
with Sp1 IRES elements
We found that nucleolin mediates Sp1 expression in a cap-
independentmanner.We then identiﬁed the speciﬁc domain important
for the recruitment of nucleolin to the Sp1 5′-UTR. Various truncated
GFP-nucleolin plasmids were constructed and transfected into HeLa
cells for immunoprecipitation analysis (Fig. 4A and 4B) by anti-GFP an-
tibodies and all of the truncated nucleolin proteins, with the exception
of GFP-NRBD, pulled down the Sp1 mRNA, suggesting that the GAR-
domain localized in the C-terminus of nucleolin was important for the
interaction between nucleolin and Sp1 mRNA (Fig. 4B (b)). Biotin-
Sp1-5′-UTR mRNA was synthesized using in vitro transcription of
pGEM-Sp1-5′-UTR to form a probe for pull down assays with cells
expressing truncated GFP-nucleolin (Fig. 4C). The loss of the GAR-
domain, represented by GFP-NRBD, abolished the interaction between
the Sp1 5′-UTR probe and nucleolin (Fig. 4C, lane 9). Bicistronic
vectors were co-transfected with plasmids encoding GFP, GFP-NCL
and GFP-NRBD to study the effect of the C-terminal nucleolin, GAR-
domain, on the translation of Sp1 mRNA (Fig. 4D and Supplementary
Fig. 3A and B). GFP-NCL overexpression in HeLa and Beas2B cells in-
creased luciferase activity and Sp1 level, but GFP-NRBD signiﬁcantlylin was knocked down by shNCL#1 and #2 in various cell lines as indicated. Samples were
s silenced by shNCL#1 in HeLa cells. Cell lysates were prepared for polysome fraction. Total
s an internal control (c). Data are representative of three independent experiments and as
2849C.-Y. Hung et al. / Biochimica et Biophysica Acta 1843 (2014) 2843–2854reversed this effect, and mutation at these two phosphorylation resi-
dues within the GAR-domain, GFP-NCL-T641A and GFP-NCL-T707A,
also reversed this effect, indicating that the phosphorylation of GAR-
domain is important for IRES-mediated Sp1 expression.Fig. 4. GAR-domain of nucleolin interacts with 5′-UTR of Sp1 mRNA. (A) Nucleolin deleted at d
constructs were transfected into HeLa cells. After 24 h incubation, total cell lysates were collec
with Western blot using anti-GFP antibodies (a). Total RNA was extracted from the immunop
nucleolin constructs were transfected in HeLa cells. Cell lysates were collected to incubate w
antibodies. (D) The pRF and pRSp1F vectors were co-transfected with GFP, GFP-nucleolin an
assay (a). The pRF and pRSp1F plasmids were transfected in HeLa cells with overexpression o
for luciferase activity assay (b). (E) GFP, GFP-NCL, GFP-NCL (T641A) and GFP-NCL (T707A) we
(b) and Western blot using antibodies against GFP, Sp1 and tubulin (a). Data are representativ3.4. Phosphorylation of nucleolin at Thr641/707 facilitates Sp1 IRES activity
In our previous studies, we identiﬁed two phosphorylation residues,
Thr641 and Thr707, within the GAR-domain [57]. Here we investigatedifferent regions as indicated here was constructed. (B) Different truncated GFP-nucleolin
ted for immunoprecipitation analysis with anti-GFP antibodies. IP samples were analyzed
recipitation samples for RT-PCR with the primers from Sp1 5′-UTR (b). (C) Different GFP-
ith 5′-UTR of Sp1 mRNA. Samples were analyzed using immunoblotting with anti-GFP
d GFP-NRBD constructs into HeLa cells for 24 h. Cell lysates were harvested for reporter
f GFP, GFP-NCL, GFP-NCL2A, GFP-NCL-641A or GFP-NCL-707A. Cell lysates were collected
re expressed in various cell lines as indicated for 24 h. Samples were harvested for q-PCR
e of three independent experiments and as mean ± s.e.m (*p b 0.05, and **p b 0.01).
Fig. 5. EGF enhances Sp1 IRES-mediated translation. Mouse primary lung cells (A) and Beas2B (B) were treated with EGF (100 ng/ml) for 0–24 h. Cell lysates were harvested forWestern
blot using antibodies against Sp1, EGFR, phospho-EGFR, ERK, phospho-ERK and tubulin (a). Total RNA was extracted from EGF-treated cells for q-PCR using the primers from Sp1 and
GAPDH (b). (C) A431 cells were treated with EGFR inhibitor, geﬁtinib, (0.1–10 μM). After treatment for 24 h, cells were harvested for immunoblotting with antibodies against
phospho-EGFR (Y1068), Sp1 and tubulin. (D) The pRF and pRSp1F vectors were transfected into A431 cells. After 12 h incubation, cells were treated with EGFR inhibitor for 2 h and
the lysates were collected for reporter analysis. (E) A431 cells were treated with various doses of geﬁtinib as indicated for 24 h. Cells were harvested for Western blot using antibodies
against phospho-nucleolin (T641), phospho-nucleolin (T707), nucleolin and tubulin. (F) A431 cells were treated with DMSO and geﬁtinib (1 and 10 μM) for 24 h and total lysates
were collected for RNA-IP with anti-nucleolin antibodies, and forWestern blot using antibodies against phospho-EGFR, nucleolin, Sp1, phospho-ERK and tubulin. Total RNA was isolated
from RNA-IP samples for RT-PCT with primers from Sp1 5′-UTR. (G) A431 cells were treated with EGF (100 ng/ml) for 0–24 h, and then cell lysates were harvested for immunoblotting
with antibodies against phospho-EGFR, nucleolin, phospho-nucleolin (T641/707) and tubulin. Data are representative of three independent experiments and asmean± s.e.m (*p b 0.05,
**p b 0.01 and ***p b 0.001).
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tion of Sp1 mRNA (Fig. 4E (b)). Mutation at the T641A/T707A sites de-
creased the effect induced by overexpression of wild-type GFP-NCL
(Fig. 4E (a)). However, GFP-NCL (T641A/T707A) was expressed at a
lower level than was wild-type GFP-NCL, suggesting that the instability
of GFP-NCL (T641A/T707A) contributes to the translational inhibition of
nucleolin-mediated Sp1 expression. This ﬁnding is consistent with our
previous study, indicating that the phosphorylation of nucleolin at
Thr641 and Thr707 increased protein stability [57]. In addition to the
regulation of nucleolin stability by these two phosphorylation residues,
we were interested in whether these two phosphorylation sites affect
IRES-mediated translational activity of Sp1-5′UTR. Data shown in
Supplementary Fig. 3D and 4 indicated that the translational activityFig. 6. Akt activation is involved in nucleolin phosphorylation at Thr641/707. (A) Samples from
nohistochemical staining (b) with antibodies against Sp1, nucleolin and phospho-nucleolin
were used to treat A431 cells for 24 h. Samples were harvested for immunoblot assay using a
Total RNA was extracted for q-PCR with primers from Sp1 and GAPDH (C (b)). (D) Overexpr
cell lines as indicated. Cell number was counted after various incubation times. Data are represeof GFP-NCL-T641A and GFP-NCL-T707A (GFP-NCL-T641A 1.5 μg and
GFP-NCL-T707A 1.25 μg) was lower than that of GFP-NCL in cells,
suggesting that nucleolin phosphorylation at these two residues not
only increases its protein stability but also induces its IRES-mediated
translation activity.
3.5. Epidermal growth factor (EGF) signaling enhances Sp1 IRES activation
With the results shown in Fig. 1, Sp1 protein, but not Sp1mRNA,was
signiﬁcantly induced in the K-rasG12D-induced lung cancer mice, imply-
ing that the K-ras pathway might contribute to the Sp1 expression. We
investigated this by EGF treatment to activate the EGFR pathway, and
then measured Sp1 protein and mRNA levels. The Sp1 protein levelK-rasG12D and EGFRL858R transgenic mice were prepared for Western blot (a) and immu-
(T641/707). (B–C) Erk1/2 inhibitor, U0126, and Akt inhibitors, LY294002 and MK2206,
ntibodies against Sp1, phospho-nucleolin (T641/707), phosphor-Akt (S473) and tubulin.
ession of GFP-NCL and its mutants, GFP-NCL (T641A) and GFP-NCL (T707A) in different
ntative of three independent experiments and as mean± s.e.m (*p b 0.05 and **p b 0.01).
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treatment (Fig. 5A and B). However, no signiﬁcant changewas observed
in the Sp1mRNA level when treatedwith EGF (Fig. 5A (b) and B (b)). An
EGFR inhibitor, geﬁtinib, was then used to block the EGFR pathway, and
the levels of Sp1, luciferase activity and phospho-nucleolin were
assessed (Fig. 5C, D and E). Sp1, luciferase activity and phospho-
nucleolin were all decreased after geﬁtinib treatment, suggesting that
EGFR-mediated nucleolin phosphorylation is involved in Sp1 expres-
sion. Geﬁtinib treatment also repressed the interaction of nucleolin
with Sp1 5′-UTR (Fig. 5F). In contrast, the levels of nucleolin and
phospho-nucleolin (T641/T707) were increased after EGF treatment,
indicating that the EGFR pathway was involved in IRES-mediated Sp1
expression (Fig. 5G). Finally, the levels of Sp1, nucleolin and phospho-
nucleolin (T641/T707) were determined in KrasG12D- and EGFRL858R-
induced lung cancermice (Fig. 6A). Hematoxylin and eosin (H&E) stain-
ing conﬁrmed lung adenocarcinoma in K-rasG12D- and EGFRL858R-
induced lung cancer mice. The levels of Sp1, nucleolin and phospho-
nucleolin were increased in tumor tissues (Fig. 6A). Inhibitors, U0126,
LY294002 and MK2206, treatment to inhibit Erk1/2 and Akt activity
respectively indicated that Akt inhibitors, LY294002 and MK2206, de-
creased the level of nucleolin phosphorylation at Thr641/707 (Fig. 6B
and C). In addition, GFP-NCL overexpression increased cell proliferation
and knockdown of Sp1 inhibited the effect by nucleolin, suggesting that
nucleolin-induced Sp1 expression increases cell proliferation (Supple-
mentary Fig. 5). Finally, mutated the phosphorylation residues, GFP-
NCL-T641A and GFP-NCL-T707A, thereby decreasing cell proliferation
(Fig. 6D), indicating that phosphorylation of nucleolin at Thr641 and
Thr707 by an EGFR pathway-activated Akt is critical for Sp1 expression
via an increase in its protein stability and translational activity.
4. Discussion
In this study, Sp1 was upregulated during tumorigenesis by activa-
tion of IRES-mediated translation. In addition, nucleolin interacted
with the Sp1 IRES element and positively regulated Sp1 IRES activation.
Furthermore, phosphorylation of nucleolin at Thr641/Thr707 by EGFR-
mediated Akt activation contributed to Sp1 IRES activity during tumor-
igenesis (Fig. 7).
Previous studies reported that Sp1 accumulated in cancer cells [1],
and showed that transcriptional activity primarily contributes most to
the increase in Sp1 during cancer formation [18,19]. However, recent
results indicated that increased Sp1 protein stability is also another
important mechanism for Sp1 accumulation during cancer formation.
For example, post-translational modiﬁcations such as phosphorylation
and sumoylation affect Sp1 stability [16,54]. Phosphorylation of Sp1 by
JNK1 protected Sp1 from proteasome-dependent degradation, andFig. 7. EGFR signaling enhances IRES-mediated translation of Sp1 during tumorigenesis. The pro
IRES-mediated translation of Sp1 in tumorigenesis.maintained Sp1 in the subsequent generation of cancer cells, and this
was not observed in the primary cells [20]. In this study, we also
found that the Erk1/2 inhibitor, U0126, did not inhibit nucleolin
phosphorylation, but it decreased the Sp1 level (Fig. 6B). It is because
Erk1/2 can phosphorylate Sp1 at Thr739 to increase its protein stability
[58,59]. Conversely, sumoylation of Sp1 recruited the ubiquitin E3-
ligase, RNF4,which contains SUMO-interactingmotifs (SIMs) that inter-
act with SUMO-modiﬁers in Sp1, leading to Sp1 polyubiquitination and
degradation [21]. In a recent study, we identiﬁed a third mechanism
that modulates Sp1 levels, the IRES pathway, which enhances the efﬁ-
ciency of Sp1 translation under hypoxic condition [22]. In the present
study, increased translational activation and protein stability as well as
IRES-mediated translational activation contributed to Sp1 accumulation
during cancer progression. Previous studies indicated that IRES-
mediated translational activity might be favored under stress condition
or sub-environment such as hypoxia or pathogen infection [38]. In this
study, we found that IRES-mediated activation of Sp1 translation also
occurred during cancer formation. Stress or hypoxia might have oc-
curred during tumorigenesis. Previous studies have also shown that
p53 and c-myc contain IRES elements that contribute to cancer progres-
sion [60–62]. Although several mechanisms can induce Sp1 expression
during cancer formation, different strategies may contribute at the
various stages of cancer progression. For example, our previous study
indicated that an increase in Sp1 sumoylation and a decrease in Sp1
phosphorylation might decrease the stability of Sp1 protein in the ma-
lignant period, leading to Sp1 degradation [17]. Understanding which
molecular mechanisms contribute to Sp1 induction at speciﬁc stages
will beneﬁt future studies investigating therapeutic strategies for
cancer.
Although our previous study shows that there is an IRES-motif found
in the 5′-UTRof Sp1 tomodulate Sp1 expression in the neuron cells [22],
the detailed mechanism of how IRES-mediated Sp1 expression is con-
trolled still remains unclear. In this study, we elucidate the mechanism
bywhich nucleolin recruited to the 5′-UTR of Sp1 contributes to Sp1 ac-
cumulation in cancer formation. Further study indicates that phosphor-
ylation of nucleolin at Thr641 and Thr707 within GAR domain is critical
for IRES-mediated Sp1 expression. The RNA-binding protein, nucleolin,
is involved in mRNA processing including the regulation of mRNA
stability and translational efﬁciency [50]. In this study, we showed
that nucleolin was recruited to the 5′-UTR motif of Sp1 mRNA to en-
hance cap-independent translational activity in cancer cells. Nucleolin
contains 4 RNA-binding domains, but the domain important for the in-
teraction with the 5′-UTR of Sp1 mRNA was not an RNA-binding do-
main, but rather the C-terminal GAR-domain of nucleolin. Previous
studies showed that the C-terminal region of nucleolin contains a
GAR-domain that interacts with target mRNA or ribosomal proteinsposedmodel shows that EGFR signaling facilitates phosphorylation of nucleolin to enhance
2853C.-Y. Hung et al. / Biochimica et Biophysica Acta 1843 (2014) 2843–2854[48,51]. In addition, other studies demonstrated that theGAR-domain of
nucleolin facilitates nucleic acid binding and nucleolar localization [63].
In a recent study, we identiﬁed that nucleolin was phosphorylated by
CDK1 at Thr641 and Thr707 localized within the C-terminal GAR-
domain, to stabilize nucleolin protein stability during mitosis [57]. In
this study, we found that these two phosphorylation residues were
important not only for the interaction with the 5′-UTR of Sp1 mRNA,
but also for Sp1 translation. Moreover, we also demonstrated that
Thr641 and Thr707 were phosphorylated not only by CDK1 during
mitosis, but also by an EGFR pathway-dependent Akt activation during
interphase. In addition, luciferase activity increase 50–100 fold in
monocistronic mRNA with 5′UTR pf Sp1 (Fig. 2F) than only 2 fold
increase in a bicistronic mRNA with 5′UTR of Sp1 in nucleolin over
expressed cells, implying that nucleoli not only involves in cap-
independent translation but also involves in the transcriptional activity
of Sp1. These results imply that nucleolin may also be involved in the
transcriptional regulation of Sp1. However, since nucleolin is not the
only factor that we predict in the 5′-UTR of Sp1, whether the other fac-
tors, hnRNP-G, PTB, hnRNP-K and hnRNP-A2/B1, also involve in the cap-
independent-mediated translation need to be addressed in the future.
In addition, although several piece of evidences shown here conclude
that nucleolin involves in IRES-mediated Sp1 translation, since
nucleolin is a multiple functional protein, we can't rule out the possibil-
ity that nucleolin modulates IRES-mediated Sp1 expression indirectly.
In conclusion, increased Sp1 transcriptional activity and Sp1protein sta-
bility have been reported to underlie Sp1 accumulation during cancer
formation. Herein, we identiﬁed a novel mechanism, the IRES-
pathway, for increasing Sp1 expression and found that nucleolin plays
a functional role in IRES activation. Our recent studies indicate that
Sp1 expression is tightly regulated in different cancer stages to modu-
late cancer progression. Further studies are required to determine
whether different mechanisms control Sp1 expression at different
stages of tumorigenesis.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.08.009.Acknowledgements
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